PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Young people aged 12 to 17 years
- People who have been formally diagnosed with post-traumatic stress disorder (PTSD) through a structured diagnostic interview
- People whose PTSD symptom score on a standardised checklist (called the CATS-2) is 25 or above at the start of the trial
- People who are already receiving care through routine child and adolescent mental health services in the regions taking part in the study
- People who have a caregiver (who has not caused the trauma) who is willing and able to take part in the caregiver parts of the treatment
- People who can communicate in Swedish well enough to take part in treatment sessions and assessments
- People who provide their own agreement to take part, with caregiver consent provided as required by age and local regulations
Who may not be able to join:
- People who are at immediate risk of suicide or self-harm at a level that requires hospital admission
- People with an active psychotic disorder or severe dissociation that would interfere with taking part
- People with autism spectrum disorder, a severe eating disorder, or obsessive-compulsive disorder where those conditions need to be the main focus of specialist treatment
- People who are still being exposed to trauma, or whose living situation is too unstable for safe participation
- People with a cognitive impairment or medical condition that would prevent them from taking part in talking therapy or the digital parts of the program
- People with a substance use disorder that requires treatment, or who use benzodiazepine medications (a type of sedative) more than once per week
- People who are currently receiving another trauma-focused therapy, who have recently started or stopped a psychiatric medication within the past six weeks, or who have a planned medication change during the study period
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Inga Dennhag, PhD, Umeå University
Phone: +46-706217414
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recruitment rate; Retention Rate; Adherence to Treatment Components; Adverse Events; Acceptability and User Experience (Qualitative Interviews)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.